Oncology & Cancer

Clinical trials confirm zolbetuximab's efficacy in gastric cancer

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of tumor-related deaths. This is due to late diagnosis and the rapid spread of tumor cells throughout ...

page 9 from 37